Researchers Develop CRISPR-Based Test for Rapid Leukemia Diagnosis
Researchers have developed a CRISPR-based diagnostic test that accurately detects gene fusions in APL and CML within two hours.
Read MorePosted by Andy Lundin | Oct 9, 2024 | Leukemia |
Researchers have developed a CRISPR-based diagnostic test that accurately detects gene fusions in APL and CML within two hours.
Read MorePosted by Andy Lundin | Oct 8, 2024 | Leukemia, Sequencing Systems |
The next-generation sequencing assay delivers rapid and comprehensive genetic profiling for AML patients, guiding precise treatment decisions.
Read MorePosted by Andy Lundin | Sep 23, 2024 | Flow Cytometry, Leukemia |
A new diagnostic classification module for AHEAD Medicine’s Cyto-Copilot platform enhances AML versus non-neoplastic classification.
Read MorePosted by Chris Wolski | Jul 4, 2024 | Sequencing Systems |
Whole genome sequencing has improved care for some children with cancer in England and can potentially replace multiple standard tests.
Read MorePosted by Chris Wolski | May 23, 2024 | Cancer |
Qlucore has released a new version of Qlucore Insights tailored for lung cancer, capable of classifying both primary and metastatic lesions.
Read More